
Keywords: Small-cell lung cancer; Chemotherapy; Epidemiology; 30-day mortality; CAV; cyclophosphamide, doxorubicin and vincristine; CbE; carboplatin + etoposide; SCLC; small-cell lung cancer; CI; confidence interval; ED-SCLC; extensive-stage small-cell lung cance